{"type":"rich","version":"1.0","provider_name":"Transistor","provider_url":"https://transistor.fm","author_name":"Science News Daily","title":"Disc Medicine’s Bitopertin Shines, Science Talent Drain Sparks Policy Debate, Vedolizumab Clears UC Without Steroids, Doughnut Model Reveals Critical Links, and more...","html":"<iframe width=\"100%\" height=\"180\" frameborder=\"no\" scrolling=\"no\" seamless src=\"https://share.transistor.fm/e/12865ff9\"></iframe>","width":"100%","height":180,"duration":739,"description":"(0:10): Disc Medicine's Bitopertin Shines in Phase 3 EPP Trial, Paving Way for FDA Submission\n(1:57): US Faces Science Talent Drain Amid Policy Shifts, Immigrant Contributions Highlighted\n(3:54): Vedolizumab Achieves Corticosteroid-Free Disease Clearance, Reduces UC Complications in Phase 4 VERDICT Trial\n(6:27): Breakthrough Study Links Topology to Critical Phenomena Using Doughnut Model\n(8:09): Japan's Leading Biobank Surpasses 250,000 Participants, Expands Global Research Access\nTo subscribe visit https://www.brief.news.\nFor more updates in your inbox each morning visit www.brief.news.\nImage credit: Shoreline Media Group","thumbnail_url":"https://img.transistorcdn.com/je4-HZPgrBlk_-irwBJ1aU1GY9y3XNHXezHh1JTxzqw/rs:fill:0:0:1/w:400/h:400/q:60/mb:500000/aHR0cHM6Ly9pbWct/dXBsb2FkLXByb2R1/Y3Rpb24udHJhbnNp/c3Rvci5mbS9zaG93/LzQ3MTgzLzE3MDY3/MjM4ODUtYXJ0d29y/ay5qcGc.webp","thumbnail_width":300,"thumbnail_height":300}